Optibiotix Health Share Discussion Threads

[rayrac] 14/6/2021 15:41

What’s all that got to do with Opti mank..can you explain? No, thought not

[rayrac] 14/6/2021 15:38

Skinny dipping again…diminishing asset

[manc10] 14/6/2021 14:28

Scientists and microbiologists have been deeply fascinated by the human microbiome for several years. But it’s only in the last five years that consumers have started to show interest. For example, looking at Google Trends worldwide search data, the human microbiome has been steadily increasing in popularity as a search term since 2007, coinciding with the National Institutes of Health’s (NIH) Human Microbiome Project (HMP).

Having initially sparked interest and furthered fascination for the human microbiome, the NIH’s investigative projectlooked to generate resources to facilitate characterisation of the human microbiome to further understand how it impacts human health and disease. The project examined the microbiomes found in the gut, nose, mouth, skin and urogenital area. Since the inception of the project, research into the gut microbiome has grown exponentially.

The Gut Microbiome

The gut microbiome is a highly complex eco-system that is home to trillions of microbial, bacterial and fungal inhabitants that contribute massively towards the body’s efforts to maintain homeostasis. The way the bacteria interact and engage with each other in the gut profoundly affects overall health.

Each human’s gut microbiome is unique to them, just like their fingerprint is. Numerous factors shape the gut microbiome’s health, such as genetics, gender, age, anthropometric parameters, exercise, geographic and socio-economic status. One of the largest determinants to impact the gut microbiome’s health is the diet1.

Extensive studies in gastrointestinal health and the gut microbiome have opened further understanding around its role and its impact on other bodily functions.

A Focus for Study

Over the past ten years, there have been a significant number of studies focusing on the gut, its microbiome and how it supports bodily functions. These studies have revealed interesting data and insight that supports long-held ideas about the relationship between the human gut and homeostasis.

Studies have shown that not only does the gut microbiome support the body’s immune system, but it also helps regulate metabolism, aids mental health and, most importantly, improves cardiovascular health.

The relationship between cardiovascular health and the gut microbiome is becoming more understood. Growing evidence from the latest studies suggests that alterations in the gut microbiome’s culture could play a role in cardiovascular disease treatment and prevention. Coupled with global cardiovascular disease levels rising, means heart health around the world is a matter of great concern. The World Health Organisation (WHO) estimates that 17.9 million people die each year, making it the number one cause of death globally.

Another fascinating area of study for the gut microbiome is in its role in modulating sleep, stress and anxiety levels in humans. In fact, there is growing scientific evidence that indicates there is now a relationship between the gastrointestinal microbiome, neurobiochemistry and emotional behaviour in humans. At OptiBiotix, we are keen to explore these areas, which is why our team is currently funding a joint study with Fondazione Edmund Mach – Centro Ricerca e Innovazione (‘FEM’) and the University of Southampton to explore the potential role microbiome modulation solutions could have in this area.

Commercial Success

Moving in tandem with science, great strides are being made in harnessing the power of innovative probiotic strains to aid human physiology and the gut microbiome. Our proprietary OptiScreen® technology platform is a high throughput pharmaceutical screening solution that identifies microbial metabolic pathways, which interact with human pathways to improve health.

Through OptiScreen, our team can identify key biomarkers with metabolic pathways that can interact with human physiological processes and derive health benefits. The process involves selecting and screening bacteria for their biological activity, identifying the best targets for development. After selection, we then test the strain in pilot scale production and effectively determine its efficacy through human intervention studies.

Our first successful application of the OptiScreen platform was in discovering LPLDL®, a naturally occurring strain of the bacterial species Lactobacillus plantarum, which was originally isolated from tomatoes. This proprietary and patented probiotic strain demonstrated excellent bile salt hydrolayse activity, alongside superb survival and metabolic activity in high concentrations of bile salts and conditions in the intestine. Following pilot scale production, we found that LPLDL offered a natural approach, with zero side effects, to reduce LDL (‘the bad’) cholesterol and improve HDL (‘the good’) cholesterol. Since then, the probiotic strain has been shown in human intervention studies to reduce blood pressure and improve cardiovascular health, alongside boosting HDL cholesterol.

This momentum of scientific study and commercial development generated by the NIH’s HMP continues to grow with scholars and scientists’ fascination in the human gut microbiome. And as global market leaders in microbiome modulation biotechnology, we will continue to explore the potential range of the gut microbiome to ensure a healthy outlook for the world’s population.

[manc10] 14/6/2021 14:22

wokeworth you bought the share with mummy and daddys money so live with it bottler

[sentiment riles] 14/6/2021 14:04

kreature filtered and reported for being SR

[kreature] 14/6/2021 13:13

still crying re my 63p dreams here. should I average sideways ?

[sentiment riles] 14/6/2021 13:03

"you know whats going to happen a tip woke worth buy the value in the company not the share price"

Seriously Manc? Ignore the one driver that determines P&L?

I cant think of any other business you could be in, where you ignore what creates the end result

[manc10] 14/6/2021 12:59

You bring zero to the table boring t÷÷t

[manc10] 14/6/2021 12:58

Woke worth all you do is whinge you should not be investing everybody know s you made a disision to invest with opti live with it thats life boo hooo

[woollworth] 14/6/2021 12:33

manc wake up before its too late, your comments fuel and help destroy confidence.

Really have no idea trying fight for your investment showing massive loss for most of us, why dont you buy soh a new car as thanks. BTW open this morning 47p, this is because the firm is on a roll not...

[manc10] 14/6/2021 11:46

lol the nhs 60 million people you are better of with 900k outlets and i cannot wait for the 3rd papers to come out for the pharma strength lpldl can you old man remember raytard pharma strength no side effects tick tock oh and ray why cant we put any ukog oil in our cars why because they dont have any like all your oilers loool

[rayrac] 14/6/2021 11:35

Why doesn’t the NHS go for LPLDL? Because it’s no good?why isn’t Slimbiome prescribed by the NHS and your dr? Because it doesn’t work?

Why pay £25 for porridge at h&b, that you can get for £1.75 at Tesco?

Mank, you are plain crazy

[manc10] 14/6/2021 11:13

anyway what you doing wokeworth watching gb news loooool

[manc10] 14/6/2021 11:05

lol we have never seen 47p before have we wokeworth lol lets see where we are in a few months and i want you to come on crying but you wont because you still hold why do you hold because deep down you know whats going to happen a tip woke worth buy the value in the company not the share price and wokeworth do some research instead of letting others do it you really dont have the balls to invest 90% of aim are running a loss

[woollworth] 14/6/2021 10:58

Why wouldn't investors kick off after sitting a loss for months, its our right.

[woollworth] 14/6/2021 10:29

Unbelievable manc, 47p this morning continue to attack others for a stock that isn't performing, many showing big loss, ramp ramp ramp, for goodness sake wake up, as is, this stock is a gravy train for management, this stock is not currently built round investors interest, new staff on loss making firm bad move.

Someone mentioned cash call, imo that is possible, especially if soh needs to fund nasdaq listing.

IMHO all your posts do nothing but harm this company, nothing you or anything we say will change the sp, have you got it yet?

[manc10] 14/6/2021 08:21

raytard you have posted the same garbage for 4 years if you want to buy lpldl go to the online store but you say you bought some err but does it exist how thick are you is age catching up ray biden

[kreature] 14/6/2021 08:14

Personally I prefer it to Aldi

[rayrac] 14/6/2021 07:48

LPLDL..ask yourself, if it’s that effective, why hasn’t the NHS shown at least some interest?! Has anyone seen it, tasted it, smelt it or even know a reason for it to exist?

[manc10] 13/6/2021 23:48

Sentiment Riles13 Jun '21 - 11:20 - 55185 of 55192 0 0 0 That’s Senti done on advfn now Another world requires full focus Plus the football of course See ya”ll down the road in some other form looool you cannot leave this thread its all you have laters

[sentiment riles] 13/6/2021 23:47

And they still make the same footprint errors , made in the past...

shocking really imo

[sentiment riles] 13/6/2021 23:45

Cenkos are working very very hard, to get distribution done and try hold the 50's (sbtx)

But I see an error in the method, opti old broker did not make

Its actually glaring...near comical